Clinical Trials Logo

Filter by:
NCT ID: NCT05280886 Recruiting - Tuberculosis Clinical Trials

Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB)

Start date: July 24, 2018
Phase:
Study type: Observational [Patient Registry]

Based on the collected antibiotic concentration data and individual patient's clinical information, a pharmacokinetic analysis report that can be applied for dose adjustment of the individual patient is provided. The pharmacokinetic/pharmacodynamic index using the minimum inhibition concentration (MIC) of the antibiotic obtained from the patient's clinical isolate is also explored. Utilizing these, we intend to establish a population pharmacokinetic model of antibiotics prescribed in treating Tuberculosis and Nontuberculous mycobacteria (NTM). The developed population pharmacokinetic model can be applied for therapeutic drug monitoring (TDM) based on dose adjustment through the obtained pharmacokinetic parameters.

NCT ID: NCT05279768 Recruiting - Clinical trials for Polycystic Ovary Syndrome

Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.

Start date: September 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to investigating the effect of Umbilical Cord Mesenchymal Stem Cell (UC-MSCs) and secretomes to insulin resistance in Polycystic Ovary Syndrome (PCOS) patients. This study has 4 arms namely UC-MSCs treatment, secretomes treatment, UC-MSCs and secretomes treatment, and control.

NCT ID: NCT05277155 Recruiting - COVID-19 Clinical Trials

Trial to Study the Efficacy and Safety of BEJO Red Ginger in COVID-19 Patients With Mild Symptoms

Start date: February 22, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

This study is a randomized, double-blind, placebo-controlled clinical trial to investigate the safety and efficacy of BEJO Red Ginger in hospitalized adult (18 - 50 years old) COVID-19 patients with mild clinical manifestations. Subjects will be screened during hospitalization. One hundred and sixty-eight patients with confirmed SARS-CoV-2 infection and meeting all criteria, will be recruited to receive either BEJO Red Ginger or placebo in addition to standard of care (SOC) in a 1:1 ratio. Patients with a diagnosis of COVID-19 and, due to mild symptoms, hospitalized, will be randomized to take a sachet of syrups containing 15 ml of BEJO Red Ginger, 3 times a day: 1 sachet after breakfast, 1 sachet after lunch, and 1 sachet after dinner, as add-on to the SOC, with 2 hours of incubation of SOC. The treatment will last for 14 days or until patients to be declared as cured. The treated patients will be compared with an equal group treated with placebo and SOC. Recovery time, symptoms, and objective (inflammatory) parameters (see detailed description) will be analyzed as outcomes. The goal of this study is to evaluate the role of BEJO Red Ginger in preventing progression of COVID-19 and accelerating healing process in patients.

NCT ID: NCT05276336 Completed - Allergic Rhinitis Clinical Trials

The Effect of Early Radiofrequency Turbinate Reduction on Persistent Allergic Rhinitis

Start date: July 1, 2018
Phase: Phase 3
Study type: Interventional

The primary outcome of this study is to evaluate the effect of radiofrequency turbinate reduction as an initial treatment on clinical improvement (using visual analogue scale based on total nasal symptoms score, peak nasal inspiratory flow, and turbinate size using ImageJ), inflammatory mediators (ELISA from nasal secretions was performed to measure ECP, IL-5, and HSP-70), and remodeling markers (through nasal biopsy followed by immunohistochemistry examination to evaluate MMP-9, TIMP-1, and PAI-1). In this randomized, controlled trial, 32 patients with moderate-severe persistent AR were randomly divided into 2 groups. Intervention group received radiofrequency turbinate reduction followed by intranasal steroid and antihistamine H-1(AH-1), control group received intranasal steroid and AH-1. Both groups were evaluated for clinical improvement in week 4 and 8 after treatment, inflammatory mediators and remodeling markers in week 4 after treatment.

NCT ID: NCT05267119 Completed - Clinical trials for Microbial Colonization

Comparison of Scalp Microbiome of Healthy Women Wearing Hijab and Those Who do Not Wear Hijab

Start date: October 1, 2019
Phase:
Study type: Observational

An observational study was performed on 48 women wearing hijab and 48 women not wearing hijab to compare the scalp microbiome.

NCT ID: NCT05265156 Terminated - Clinical trials for Healthy Young Children

An Evaluation of the Tolerability and Acceptability of a New Plant-based Formula for Young Children

Start date: January 7, 2022
Phase: N/A
Study type: Interventional

An evaluation of the tolerability and acceptability of a new plant-based formula in 45 healthy young children

NCT ID: NCT05264766 Completed - Clinical trials for Heart; Surgery, Heart, Functional Disturbance as Result

The Use of Cooling Helmet for Neuroprotection Management in Open Heart Surgery

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

To know the relationship between the use of cooling helmet with the changes of NSE level and postoperative delirium event in open heart surgery

NCT ID: NCT05261750 Recruiting - Clinical trials for Nasopharyngeal Cancer

Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer

Start date: April 30, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and potential of dendritic cells therapy and secretomes therapy for advanced nasopharyngeal cancer.

NCT ID: NCT05254249 Recruiting - Psoriasis Vulgaris Clinical Trials

Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris

Start date: February 7, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

Psoriasis is a chronic inflammatory skin disease (chronic and recurrent) which is influenced by various factors, namely genetics, immunological processes, and environmental triggers such as infection, obesity, smoking, and drugs. The provision of probiotic Lactobacillus plantarum IS-10506, an Indonesian original probiotic strain, is expected to be an effective, safe, and affordable alternative for psoriasis treatment for psoriasis patients in Indonesia. This study aimed to evaluate changes in gut microbiota profile, cytokines IL-17, TNF-a, IL-10, Foxp3, and disease severity of psoriasis vulgaris patients after supplementation with Lactobacillus plantarum IS-10506. The results of this study are expected to be the basis for the use of Lactobacillus plantarum IS-10506 in the therapy of psoriasis vulgaris which is included in the Clinical Practice Guide in Indonesia, which will ultimately help improve the quality of life of psoriasis patients.

NCT ID: NCT05254028 Completed - Clinical trials for Tension-Type Headache

The Effectiveness of Auricular Point Compared to Body Point Acupuncture Theraphy on Tension-Type Headache

Start date: December 27, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effectiveness of manual acupuncture between 2 types of points in decreasing tension-type headache symptoms of healthcare workers in Dr.Cipto Mangunkusumo hospital